NYSEARCA:MRNY YieldMax MRNA Option Income Strategy ETF (MRNY) Price, Holdings, & News $2.38 -0.04 (-1.65%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$2.41 +0.03 (+1.26%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipShort InterestBuy This Stock About YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MRNY alerts:Sign Up Key Stats Today's Range$2.35▼$2.4650-Day Range$2.25▼$2.7552-Week Range$2.20▼$16.03Volume3.36 million shsAverage Volume1.08 million shsMarket Capitalization$107.81 millionAssets Under Management$117.31 millionDividend Yield147.90%Net Expense Ratio1.27%Aggregate RatingN/A ETF Overview The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax. Read More YieldMax MRNA Option Income Strategy ETF ExpensesTypeMRNYSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.99%0.93%0.56%0.51%0.53%Other Expenses0.28%0.64%0.56%0.59%0.56%Total Expense1.27%1.35%0.76%0.74%0.73%Fee Waiver0.00%-1.01%-0.66%-0.71%-0.63%Net Expense1.27%1.03%0.63%0.58%0.60% Receive MRNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YieldMax MRNA Option Income Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNY ETF News HeadlinesYieldMax® ETFs Announces Distributions on MARO, MRNY, ULTY, NVDY, LFGY, and OthersJuly 16 at 6:55 AM | globenewswire.comMRNY: Poor Performance Due To Moderna's DeclineJuly 7, 2025 | seekingalpha.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history. | Paradigm Press (Ad)MRNY YieldMax MRNA Option Income Strategy ETF - Seeking AlphaJune 24, 2025 | seekingalpha.comYieldMax MRNA Option Income Strategy ETF (MRNY) Dividend HistoryMarch 30, 2025 | nasdaq.comYieldMax PLTR Option Income Strategy ETF declares $5.9377 dividendFebruary 27, 2025 | msn.comSee More Headlines MRNY ETF - Frequently Asked Questions How have MRNY shares performed this year? YieldMax MRNA Option Income Strategy ETF's stock was trading at $5.26 on January 1st, 2025. Since then, MRNY shares have decreased by 54.8% and is now trading at $2.38. How do I buy shares of YieldMax MRNA Option Income Strategy ETF? Shares of MRNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of YieldMax MRNA Option Income Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that YieldMax MRNA Option Income Strategy ETF investors own include YieldMax NVDA Option Income Strategy ETF (NVDY), YieldMax COIN Option Income Strategy ETF (CONY), YieldMax META Option Income Strategy ETF (FBY), Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF (QQQY), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Oxford Lane Capital (OXLC) and YieldMax AMZN Option Income Strategy ETF (AMZY). Fund Details IssuerElevate Shares Fund NameYieldMax MRNA Option Income Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MRNY Inception Date10/23/2023 Fund ManagerMick Brokaw, Jay Pestrichelli, Qiao Duan, Charles Ragauss WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings14 Fund Statistics Assets Under Management$117.31 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorToroso Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume79 Put Options53 Call Options26 Short Interest490,400 shs Miscellaneous Outstanding Shares45,300,000Beta0.98 Creation Fee$300.00 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Top 10 MRNY HoldingsUnited States Treasury Notes 3.88%Holding Weight: 32.38%MRNA US 07/18/25 C25Holding Weight: 28.16%United States Treasury Notes 4.25%Holding Weight: 19.79%United States Treasury Bills 0%Holding Weight: 10.59%United States Treasury Bills 0%Holding Weight: 8.61%United States Treasury Notes 3%Holding Weight: 7.27%United States Treasury Bills 0%Holding Weight: 4.69%Cash OffsetHolding Weight: 1.99%First American Government Obligations FundHolding Weight: 1.14%DEPOSITS WITH BROKER FOR SHORT POSITIONSHolding Weight: 0.77%Full Holdings Details This page (NYSEARCA:MRNY) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YieldMax MRNA Option Income Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share YieldMax MRNA Option Income Strategy ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
